Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PALI

PALI News

Newswire

09:02

Palisade Bio Appoints James Izanec as Vice President, Clinical Development.

07:48

Palisade Bio's Significant Individual Investors Ownership Influences Market Cap Growth

10:54

Palisade Bio shares up 10.35% intraday after Q3 2025 report removes going concern doubts with $138M financing.

09:35

Palisade Bio shares rise 14.44% intraday after Maxim raises price target to $8 from $2 with Buy rating.

08:49

Palisade Bio Names Sharon Skare as Vice President of Clinical Operations.

View More

About PALI

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More